glp-1 therapy weight loss milestones timeline Historical of biology, receptor agonist discovery, and Market Overview: GLP-1 Agonists and
Description
high discontinuation rates (e.g., 50-67% at 1 year and 85% at 2 years 5-8 ) that may relate to side effects, costs, variable individual efficacy, or patient preferences 5,9
The result is that people feel full faster, stay full longer, and eat less without feeling like they are constantly fighting hunger
doi: 10.1111/dom.13374
An update on the safety of SGLT2 inhibitors
Patent expiries are creating opportunities for generics
Here, we will discuss in-depth the actions of GLP-1 and its analogues in immunomodulation and related signal pathways in the setting of a number of diseases
